Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sharma East India Hospitals & Medical Research (BOM:524548) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Sharma East India Hospitals & Medical Research ROCE % Related Terms
Sharma East India Hospitals & Medical Research ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research ROCE % Chart
Sharma East India Hospitals & Medical Research Annual Data
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research (BOM:524548) has a ROCE % of 16.32% as of Mar. 2026.
Is Sharma East India Hospitals & Medical Research's ROCE % too high?
Sharma East India Hospitals & Medical Research's current ROCE % is 16.32%. The Healthcare Providers & Services industry median ROCE % is 6.36. Sharma East India Hospitals & Medical Research's value of 16.32% is 156.6% above this industry median. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's ROCE % compare to HCA and THC?
Sharma East India Hospitals & Medical Research's ROCE % of 16.32% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.36. Sharma East India Hospitals & Medical Research's value of 16.32% is 156.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.36, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sharma East India Hospitals & Medical Research's current ROCE % of 16.32% is 156.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sharma East India Hospitals & Medical Research's current ROCE % is 16.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Fairly Valued. The stock's GF Value™ is ₹101.98, compared to a current price of ₹100.00 — trading 1.9% below its estimated fair value. The current ROCE % is 16.32% and 156.6% above the Healthcare Providers & Services industry median of 6.36. Sharma East India Hospitals & Medical Research's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current ROCE % is 16.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued.
The current stock price of ₹100.00 is trading 1.9% below its estimated GF Value™ of ₹101.98.
GuruFocus considers Sharma East India Hospitals & Medical Research to be Fairly Valued.
Key valuation signals for BOM:524548:
ROCE %: 16.32%
GF Value™: ₹101.98 vs. price of ₹100.00 (1.9% below fair value)
Industry Position: 156.6% above the Healthcare Providers & Services median
No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sharma East India Hospitals & Medical Research Business Description
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
77GF Score
Get the complete analysis for BOM:524548
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524548 has been successfully added to your 
